When applied to the scalp, exosomes deliver these regenerative signals directly to dormant hair follicles, encouraging them to re-enter the active growth phase
At present, there are no established transplant-selection criteria, mandatory waiting periods or surgical protocols for this population
The growth of the oral GLP-1 agonist market in the Middle East & Africa region is slow and steady, observing significant growth in prescription patterns owing to growing awareness of chronic and lifestyle diseases coupled with massive development of healthcare facilities and systems
Pure Encapsulations achieves this by utilizing biologically active, pre-converted forms of vitamins that do not require complex hepatic (liver) processing
While results from IV ALA studies are consistently positive, the picture is more mixed when it comes to oral-only supplementation: A four-year randomized trial found no significant improvement in a composite measure of nerve function with 600mg/day of oral ALA compared to placebo
It helps the process of reducing oxidized glutathione